Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.38 |
| ▸ | F2 | P00734 | 4/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ANO1 | Q5XXA6 | 4/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5089044 | 0.99 | F10 (0.38) | F10F2ITGB3ITGA2BEGFR | |
| Hydrochloric Acid SCHEMBL5099591 | 0.93 | EGFR (0.36) | F10F2ITGB3ITGA2BEGFR | |
| Hydrochloric Acid SCHEMBL5089064 | 0.91 | ITGB3 (0.37) | F10F2ITGB3ITGA2BALDH1A1 | |
| Hydrochloric Acid SCHEMBL5098935 | 0.87 | MEN1 (0.36) | F10F2ITGB3ITGA2BALDH1A1 | |
| SCHEMBL6556891 | 0.86 | F2 (0.39) | F10F2ITGB3ITGA2BPRSS1 | |
| Hydrochloric Acid SCHEMBL6554847 | 0.85 | F2 (0.39) | F10F2ITGB3ITGA2BPRSS1 | |
| Hydrochloric Acid SCHEMBL5093188 | 0.82 | ITGB3 (0.39) | F10F2ITGB3ITGA2BEGFR | |
| SCHEMBL6554459 | 0.77 | F10 (0.40) | F10F2PRSS1 | |
| Hydrochloric Acid SCHEMBL6555877 | 0.76 | F10 (0.39) | F10F2PRSS1 | |
| SCHEMBL7560179 | 0.76 | F10 (0.38) | F10F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7425641-B2 | Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2008-09-16 | — | — | US | claimed |
| US-20050065346-A1 | Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-03-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065346-A1 | Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions | F12, F11, F2 | F10 23/4885F2 3/4885ITGB3 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.